Contribution: Industrial Research Assistance Program – Contributions to Firms
Mannin Research Inc
$6,860,170.00
COVID-19: Pre-clinical development of a therapeutic to treat Acute Respiratory Distress Syndrome in COVID-19
FY 2020-21 · 2021-02-09
Summary
Development of methodology for purification and pre-clinical testing of a therapeutic to prevent vascular leakage in Acute Respiratory Distress Syndrome.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
For-profit organization
Business Number
803496488
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-02-09 | 2020-21 | $1,799,444.00 |
| 1 | 2021-02-09 | 2020-21 | $1,799,444.00 |
| 2 | 2021-02-09 | 2020-21 | $3,489,024.00 |
| 3 | 2021-02-09 | 2020-21 | $3,489,024.00 |
| 4 | 2021-02-09 | 2020-21 | $6,860,170.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 164 days. The total amended value is 3,371,146 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 164 jours. La valeur totale des modifications est de 3 371 146 dollars.
Agreement End Date
2023-05-15
Agreement Number
967028
Agreement Start Date
2021-02-09
Agreement Title
COVID-19: Pre-clinical development of a therapeutic to treat Acute Respiratory Distress Syndrome in COVID-19
Agreement Title (French)
COVID-19 : Mise au point préclinique d'un médicament pour traiter le syndrome de détresse respiratoire aiguë de la COVID-19
Agreement Type
Contribution
Agreement Value
$6,860,170.00
Amendment Date
2022-12-09
Amendment Number
4
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Development of methodology for purification and pre-clinical testing of a therapeutic to prevent vascular leakage in Acute Respiratory Distress Syndrome.
Description (French)
Mise au point d'une méthodologie pour la purification et les essais précliniques d'un produit thérapeutique destiné à prévenir la fuite vasculaire dans le syndrome de détresse respiratoire aiguë.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Toronto--Danforth
Federal Riding (French)
Toronto--Danforth
Federal Riding Number
35109
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
803496488
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
Mannin Research Inc
Recipient Postal Code
M4M 1E4
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2020-2021-Q4-967028
